Pyrimethamine Market Overview:
Pyrimethamine Market size was valued at USD 1,000 million in 2021 and is projected to reach around USD 1,650 million in 2030 exhibiting a CAGR of 5.0% in the forecasted period. Pyrimethamine is typically given in combination with sulfa and folinic acid because to its resistance to numerous Plasmodium species. It has also been discovered that pyrimethamine restricts the expression of the superoxide dismutase 1 gene, which codes for a protein linked to amyotrophic lateral sclerosis.
One medication used to treat protozoan infections is pyrimethamine. Pyrimethamine is a member of the ant parasitic drug class. It functions by parasite death. It’s widely used to treat infections caused by Toxoplasma Gondi, as well as an antimalarial (for the treatment and prevention of malaria). When combined with sulpha sulfadiazine, it’s also used to treat HIV-positive individuals. A dangerous, potentially lethal, and life-threatening infection is toxoplasmosis.
Get free access to sample report @ https://wemarketresearch.com/sample-request/pyrimethamine-market/867
Market Opportunities:
Increasing Research and Drug Development Initiatives
For producers in the worldwide pyrimethamine market, technological breakthroughs and quick innovation in medication discovery and development—particularly in personalized medicine—create substantial opportunity. This is yet another element predicted to fuel the global market for pyrimethamine’s expansion.
Growing Toxoplasmosis Cases
One of the five parasite infections that go untreated in the United States, according to The Centers for Disease Control and Prevention (CDC), is toxoplasmosis. More than 60 million Americans carry the toxoplasma parasite, which causes more than one million infections annually and is linked to high rates of morbidity and mortality. It is the second most common cause of foodborne illness-related death in the nation.
Significant components of the research:
The study on the global pyrimethamine market serves a range of industry participants, such as financiers, suppliers, manufacturers, distributors, investors, and newcomers.
Using 2021 as the base year, this research offers a thorough study of the global pyrimethamine market, including market size (US$ million) and compound annual growth rate (CAGR%) for the projected period (2022–2030).
It presents appealing investment proposition matrices for this market and clarifies possible revenue prospects across several segments.
Important information is also provided by this report regarding market trends, regional outlooks, opportunities, opportunities, constraints, and competitive strategies used by major competitors, as well as new product launches or approvals.
Based on the following criteria—company features, types portfolio, significant highlights, financial performance, and market strategies—it profiles major participants in the global pyrimethamine market.
Ask for Customization: https://wemarketresearch.com/customization/pyrimethamine-market/867
Market Segmentations:
By Disease Type
- Toxoplasmosis
- Malaria
- Others
By Route of Administration
- Oral
- Parenteral
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Geographically Analysis:
While pyrimethamine can induce cancer cells to undergo apoptosis, North America is predicted to lead the world market for this drug due to an increase in cancer cases and chemotherapy procedures in the area. For example, according to the American Cancer Society’s 2019–2021 Cancer Survival and Treatment Data and Data Report, as of January 1, 2019, the estimated number of cancer cases in the United States was around 16,920,370.
However, due to increased government awareness campaigns, a higher prevalence of malaria and AIDS, and other factors, Asia-Pacific has been witnessing favorable growth for the global pyrimethamine market throughout the projected decade.
Some Leading Companies Involved in this market are:
- Vera Pharmaceuticals, LLC
- Carotene Healthcare PVT. LTD
- GlaxoSmithKline plc
- Imax Laboratories, Inc.
- NCBO Bio Portal
- Pfizer, Inc.
- PRN Pharma Cal
- SUDA Pharmaceuticals
- Taj Acura Pharmaceuticals
- Target MO Chemicals Inc.
- Evaluate Ltd.
- Abeam
- Other players
Get a Purchase of This Report @ https://wemarketresearch.com/purchase/pyrimethamine-market/867?license=single
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: [email protected]
